{"id":146976,"date":"2025-04-03T14:32:41","date_gmt":"2025-04-03T09:02:41","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=146976"},"modified":"2025-04-03T14:32:44","modified_gmt":"2025-04-03T09:02:44","slug":"pharma-stock-jumps-12-after-signing-contract-with-europe-based-company","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-signing-contract-with-europe-based-company\/","title":{"rendered":"Pharma stock jumps 12% after signing contract with Europe based company"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-719468085\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>The Indian Pharma Industry is expected to reach $130 billion by 2030 from existing $49.78 billion as of 2023, with a CAGR of 14.7 percent. About 30 percent of Indian Pharmaceutical exports are accounted by US alone.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-113402776\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>On 3 April 2025, the US administration announced that it would exempt India\u2019s pharma industry from reciprocal tariffs. In this article, we would look at one company which will benefit from recent developments.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Price Movement<\/strong><\/h2><p>With a market capitalization of Rs 677 crore, the shares of <strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/MEDICAMEQ\" target=\"_blank\" rel=\"noreferrer noopener\">Medicamen Biotech Ltd <\/a><\/strong>made a 52-week high of Rs 630 per share, down by 15 percent from its current market price of Rs 533.30 per share.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>About the announcement<\/strong><\/h2><p>On 3 April 2025, the company announced that it had signed a contract for Contract Development and Manufacturing Organization (CDMO) with XGX Pharma (European company), where Medicamen Biotech will develop 6 products and will do the manufacturing of these products for XGX Pharma. XGX will hold the market authorisation for these products.<\/p><div class=\"trade-content_5\" id=\"trade-1258277616\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>XGX Pharma develops and distributes specialty generic pharmaceuticals. Based in Copenhagen, Denmark, it primarily operates in the Nordic region but is expanding internationally.&nbsp;<\/p><p>XGX Pharma works with partners to enhance its market reach and has agreements with companies like Medicamen Biotech to manufacture and develop its products. The company holds the market authorizations for these products in various regions.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Financials<\/strong><\/h2><p>Medicamen Biotech Ltd reported a revenue of Rs 45.14 crore in Q3 FY25, down by 2.9 percent, from its Q3 FY24 revenue of Rs 46.50 crore. It posted a net profit of Rs 2.92 crore in Q3 FY25, up by 43.8 percent, from its Q3 FY24 net profit of Rs 2.03 crores and up by 220 percent from its Q2 FY25 net profit of Rs 0.91 crores.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>About the Company<\/strong><\/h2><p>Medicamen Biotech Limited is a pharmaceutical company that researches, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally.&nbsp;<\/p><p>The company offers drugs in various forms such as tablets, capsules, oral solution, and drops. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-malarial, vitamins and supplements, other generics, and pain management.&nbsp;<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by Satyajeet Mukherjee<\/strong><\/p>\n\n<p class=\"has-medium-font-size\"><strong>Disclaimer<\/strong><\/p>\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div>\n\n<p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on <a href=\"http:\/\/tradebrains.in\/\">tradebrains.in<\/a> are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><\/blockquote><div class=\"trade-after-content\" id=\"trade-2216663637\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>The Indian Pharma Industry is expected to reach $130 billion by 2030 from existing $49.78 billion as of 2023, with a CAGR of 14.7 percent. About 30 percent of Indian Pharmaceutical exports are accounted by US alone.&nbsp; On 3 April 2025, the US administration announced that it would exempt India\u2019s pharma industry from reciprocal tariffs. [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":111747,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[27807,27804,27806,6616,15654,948,936,3157,2597],"class_list":["post-146976","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-medicamen-biotech-ltd-announcement","tag-medicamen-biotech-ltd-latest-news","tag-medicamen-biotech-ltd-news","tag-pharma-stock","tag-pharma-stock-news","tag-stock-market","tag-stock-market-news","tag-stock-to-watch","tag-stocks-to-watch"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock jumps 12% after signing contract with Europe based company<\/title>\n<meta name=\"description\" content=\"The Indian Pharma Industry is expected to reach $130 billion by 2030 from existing $49.78 billion as of 2023, with a CAGR of 14.7 percent.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-signing-contract-with-europe-based-company\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock jumps 12% after signing contract with Europe based company\" \/>\n<meta property=\"og:description\" content=\"The Indian Pharma Industry is expected to reach $130 billion by 2030 from existing $49.78 billion as of 2023, with a CAGR of 14.7 percent.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-signing-contract-with-europe-based-company\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-03T09:02:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-03T09:02:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-signing-contract-with-europe-based-company\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-signing-contract-with-europe-based-company\/\",\"name\":\"Pharma stock jumps 12% after signing contract with Europe based company\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-signing-contract-with-europe-based-company\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-signing-contract-with-europe-based-company\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"datePublished\":\"2025-04-03T09:02:41+00:00\",\"dateModified\":\"2025-04-03T09:02:44+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"The Indian Pharma Industry is expected to reach $130 billion by 2030 from existing $49.78 billion as of 2023, with a CAGR of 14.7 percent.\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-signing-contract-with-europe-based-company\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-signing-contract-with-europe-based-company\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-signing-contract-with-europe-based-company\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-signing-contract-with-europe-based-company\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock jumps 12% after signing contract with Europe based company\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock jumps 12% after signing contract with Europe based company","description":"The Indian Pharma Industry is expected to reach $130 billion by 2030 from existing $49.78 billion as of 2023, with a CAGR of 14.7 percent.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-signing-contract-with-europe-based-company\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock jumps 12% after signing contract with Europe based company","og_description":"The Indian Pharma Industry is expected to reach $130 billion by 2030 from existing $49.78 billion as of 2023, with a CAGR of 14.7 percent.","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-signing-contract-with-europe-based-company\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2025-04-03T09:02:41+00:00","article_modified_time":"2025-04-03T09:02:44+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-signing-contract-with-europe-based-company\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-signing-contract-with-europe-based-company\/","name":"Pharma stock jumps 12% after signing contract with Europe based company","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-signing-contract-with-europe-based-company\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-signing-contract-with-europe-based-company\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","datePublished":"2025-04-03T09:02:41+00:00","dateModified":"2025-04-03T09:02:44+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"The Indian Pharma Industry is expected to reach $130 billion by 2030 from existing $49.78 billion as of 2023, with a CAGR of 14.7 percent.","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-signing-contract-with-europe-based-company\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-signing-contract-with-europe-based-company\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-signing-contract-with-europe-based-company\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-signing-contract-with-europe-based-company\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock jumps 12% after signing contract with Europe based company"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/146976","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=146976"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/146976\/revisions"}],"predecessor-version":[{"id":146980,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/146976\/revisions\/146980"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/111747"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=146976"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=146976"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=146976"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}